GSTP1 and Familial prostate cancer: Although GSTP1 expression has been estimated to be maintained in 5–10% of prostate cancer cases, little is known about the molecular and clinical features of these cases and only a few studies have directly asked the question of the frequency of positive GSTP1 Immunohistochemical (IHC) staining in prostate cancer [16,17].